Open Veils · Answer
Post tubal ligation syndrome
PTLS sits in the same suppressed-symptom graveyard as premenstrual dysphoric disorder and endometriosis did before patient pressure forced reclassification. Thousands of women report identical symptom clusters — hormonal disruption, menorrhagia, early menopause signals, mood collapse — after tubal ligation, yet institutional gynecology refuses a diagnostic code. The evidence base is contested but not absent: a 2026 meta-analysis found a measurable association between tubal ligation and subsequent menorrhagia, while a 2025 scoping review confirmed menstrual bleeding changes in several large cohort studies, particularly in Iranian and Pakistani populations. The pattern of dismissal follows the same institutional logic that delayed recognition of silicone implant illness and chemical sensitivity for decades.
Evidence
- The term PTLS was popularized largely through patient advocacy networks and practitioners operating outside mainstream obstetrics-gynecology.
- Her thesis: the utero-ovarian ligament and associated blood vessels, when damaged during ligation, reduce ovarian perfusion, leading to premature decline in estrogen and progesterone without technically meeting the threshold for 'premature ovarian failure' on standard labs.
- Jack Kruse's circadian-biology framework would add that post-surgical disruption of pelvic innervation and blood flow alters mitochondrial function in ovarian tissue, a mechanism entirely invisible to standard hormonal panels.